Susquehanna International Group, LLP Exagen Inc. Call Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$2.1 - $3.4 $23,100 - $37,400	-11,000 Reduced 13.41%	71,000 $170,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $8.68 $179,732 - $454,832	-52,400 Reduced 38.99%	82,000 $222,000
Q2 2022 Aug 15, 2022	BUY	$4.18 - $7.74 $54,757 - $101,394	13,100 Added 10.8%	134,400 $771,000
Q1 2022 May 16, 2022	BUY	$7.12 - $11.06 $863,656 - $1.34 Million	121,300 New	121,300 $974,000

6.21M

1.6K

4.1K

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $28.9M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.